MTOR and cancer: Our study examining the role of the mammalian target of rapamycin (mTOR) signaling pathway in the regulation of NET formation did investigate rapamycin, an immunosuppressant and chemotherapeutic agent used in solid organ transplantation and some cancer treatment regimens, as an inhibitor of NET formation.